^
over1year
P1 data • PK/PD data • Journal • Metastases
|
SHR-1802
over1year
A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors (clinicaltrials.gov)
P1/2, N=132, Recruiting, Shanghai Hengrui Pharmaceutical Co., Ltd. | Not yet recruiting --> Recruiting
Enrollment open • Combination therapy • Metastases
|
cisplatin • carboplatin • albumin-bound paclitaxel • pemetrexed • Ariely (adebrelimab) • SHR-1802
over2years
A Study of SHR-1802 in Patients With Advanced Solid Tumor (clinicaltrials.gov)
P2, N=124, Recruiting, Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting --> Recruiting
Enrollment open
|
CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule)
|
AiRuiKa (camrelizumab) • famitinib (SHR 1020) • SHR-1802
almost3years
A Study of SHR-1802 in Patients With Advanced Solid Tumor (clinicaltrials.gov)
P2, N=124, Not yet recruiting, Jiangsu HengRui Medicine Co., Ltd.
New P2 trial
|
CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule)
|
AiRuiKa (camrelizumab) • famitinib (SHR 1020) • SHR-1802